Editage
Research Solutions English Editing AI Solutions Publication Support Journal Finder Corporate Solutions More

Drug Resistance Updates

eISSN: 1532-2084pISSN: 1368-7646

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Key Metrics

CiteScore
30.8
Eigenfactor
0.001 - 0.005
H-Index
125
Impact Factor
20 - 25
SJR
Q1Oncology
SNIP
3.67
Time to Publish
time-to-publish View Chart
2  Mo

Journal Specifications

Overview
  • Publisher
    CHURCHILL LIVINGSTONE
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 84%
4-6 16%
7-9 0%
>9 0%

Topics Covered

Clinical evidence
Ovarian cancer
Immunotherapy
Glioblastoma
Bacterial persistence
Antitumor immunity
Drug resistance
Homologous recombination
Prostate cancer
Paclitaxel
Autophagy
Tumor microenvironment
Drug response
High-grade serous carcinoma
Enterococcus
Tumor immunity
Homologous Recombination Deficiency
Docetaxel
Vancomycin resistance
Immune checkpoint inhibitors

Recently Published Papers

Year-wise Publication

FAQs

Since when has Drug Resistance Updates been publishing? Faqs

The Drug Resistance Updates has been publishing since 1998 till date.

How frequently is the Drug Resistance Updates published? Faqs

Drug Resistance Updates is published Bi-monthly.

What is the H-index. SNIP score, Citescore and SJR of Drug Resistance Updates? Faqs

Drug Resistance Updates has a H-index score of 125, Citescore of 30.8, SNIP score of 3.67, & SJR of Q1

Who is the publisher of Drug Resistance Updates? Faqs

The publisher of Drug Resistance Updates is CHURCHILL LIVINGSTONE.

How can I view the journal metrics of Drug Resistance Updates on editage? Faqs

For the Drug Resistance Updates metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Drug Resistance Updates? Faqs

The eISSN number is 1532-2084 and pISSN number is 1368-7646 for Drug Resistance Updates.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Clinical evidence, Ovarian cancer, Immunotherapy, Glioblastoma, Bacterial persistence, Antitumor immunity, Drug resistance, Homologous recombination, Prostate cancer, Paclitaxel, Autophagy, Tumor microenvironment, Drug response, High-grade serous carcinoma, Enterococcus, Tumor immunity, Homologous Recombination Deficiency, Docetaxel, Vancomycin resistance, Immune checkpoint inhibitors.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.